MYCN and neuroblastoma: In NB, high expression of an SGOC gene signature (49) or glycine decarboxylase (50), the enzyme which catalyzes glycine breakdown to produce one-carbon metabolism intermediate 5,10-methylene-tetrahydrofolate, was identified in MYCN-amplified patients and was associated with advanced disease stage and poor prognosis.